Buscar
-
Demandes d'études post-inscription (EPI), suivi des patients en vie réelle : évolution de la place des bases de données
(Thérapie. vol. 73, n° 1, pp. 1-12, 2018-02)Article de revue -
Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study
(Pharmacoepidemiology and drug safety. vol. 27, n° 11, pp. 1174-1181, 2018-11)Article de revue -
Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
(Clinical Colorectal Cancer. vol. 17, n° 2, pp. 129-139, 2018-06)Article de revue -
Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics
(Postgraduate medicine. vol. 130, n° 2, pp. 188-199, 2018-03)Article de revue -
Effectiveness and safety of standard and reduced doses of dabigatran versus rivaroxaban in non-valvular atrial fibrillation: A cohort study in the snds french nationwide claims database
(Value Health. vol. 21, pp. S7-S7, 2018-10)Article de revue -
Benefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: results from a cohort study in the French nationwide claims database
(European Heart Journal. vol. 39, pp. 822-822, 2018-08)Article de revue -
Drug exposure and risk of Acute Liver Failure leading to registration for liver Transplantation (ALFT): Results of the SALT III study in adults in France
(J. Hepatol.. vol. 68, pp. S587-S588, 2018-04)Article de revue -
SNDS, the french nationwide claims database: A powerful tool for pharmacoeconomy and pharmacoepidemiology
(Value Health. vol. 21, pp. S371-S371, 2018-10)Article de revue